{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:56:57Z","timestamp":1793141817313,"version":"4.5.0"},"reference-count":136,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Center for Cancer Research, National Cancer Institute","award":["ZIA BC 012079"],"award-info":[{"award-number":["ZIA BC 012079"]}]},{"name":"Center for Cancer Research, National Cancer Institute","award":["ZIA BC 012083"],"award-info":[{"award-number":["ZIA BC 012083"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK121330"],"award-info":[{"award-number":["DK121330"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK122708"],"award-info":[{"award-number":["DK122708"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK122796"],"award-info":[{"award-number":["DK122796"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2023,5,5]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Viral hepatitis, alcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are the three major causes of chronic liver diseases, which account for approximately 2\u2009million deaths per year worldwide. The current direct-acting antiviral drugs and vaccinations have effectively reduced and ameliorated viral hepatitis infection, but there are still no effective drug treatments for ALD, NAFLD and liver cancer due to the poor understanding of their pathogenesis. To better understand the pathogenesis, the fifth Chinese American Liver Society\/Society of Chinese Bioscientists in America Hepatology Division Annual Symposium, which was held virtually on 21\u201322 October 2022, focused on the topics related to ALD, NAFLD and liver cancer. Here, we briefly highlight the presentations that focus on the current progress in basic and translational research in ALD, NAFLD and liver cancer. The roles of non-coding RNA, autophagy, extrahepatic signalling, macrophages, etc in liver diseases are deliberated, and the application of single-cell RNA sequencing in the study of liver disease is also discussed.<\/jats:p>","DOI":"10.1136\/egastro-2023-100020","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T20:50:44Z","timestamp":1697748644000},"page":"e100020","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases"],"prefix":"10.1136","volume":"1","author":[{"given":"Yankai","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, University of Texas McGovern Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Ma","sequence":"additional","affiliation":[{"name":"Cancer Data Science Laboratory, National Cancer Institute Center for Cancer Research, Bethesda, Maryland, USA"},{"name":"Liver Cancer Program, National Cancer Institute Center for Cancer Research, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, University of Texas McGovern Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"2025081719112701000_1.2.e100020.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2025081719112701000_1.2.e100020.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.09.002"},{"key":"2025081719112701000_1.2.e100020.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2018.09.002"},{"key":"2025081719112701000_1.2.e100020.4","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025081719112701000_1.2.e100020.5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025081719112701000_1.2.e100020.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00688-6"},{"key":"2025081719112701000_1.2.e100020.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"2025081719112701000_1.2.e100020.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.05.003"},{"key":"2025081719112701000_1.2.e100020.9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32744-2"},{"key":"2025081719112701000_1.2.e100020.10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-physiol-060821-014008","article-title":"Alcohol-associated tissue injury: current views on pathophysiological mechanisms","volume":"84","author":"Simon","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"2025081719112701000_1.2.e100020.11","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/acer.13078","article-title":"A mechanistic review of cell death in alcohol-induced liver injury","volume":"40","author":"Wang","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"2025081719112701000_1.2.e100020.12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2025081719112701000_1.2.e100020.13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/CS20171055","article-title":"Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease","volume":"132","author":"St\u00e4rkel","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"2025081719112701000_1.2.e100020.14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184568","article-title":"Alcohol or gut microbiota: who is the guilty?","volume":"20","author":"Meroni","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025081719112701000_1.2.e100020.15","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.2021.16070","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"2025081719112701000_1.2.e100020.16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jhep.2022.03.025","article-title":"Therapeutic advances in alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"J Hepatol"},{"key":"2025081719112701000_1.2.e100020.17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27036"},{"key":"2025081719112701000_1.2.e100020.18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316221"},{"key":"2025081719112701000_1.2.e100020.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102577","article-title":"ALDH2 deficiency increases susceptibility to binge alcohol-induced gut Leakiness, endotoxemia, and acute liver injury in mice through the gut-liver axis","volume":"59","author":"Rungratanawanich","year":"2023","journal-title":"Redox Biol"},{"key":"2025081719112701000_1.2.e100020.20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2019.06.018","article-title":"ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles","volume":"71","author":"Seo","year":"2019","journal-title":"J Hepatol"},{"key":"2025081719112701000_1.2.e100020.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.022"},{"key":"2025081719112701000_1.2.e100020.22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.redox.2017.11.005","article-title":"Mitochondria-targeted Ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of Aldehyde dehydrogenase 2: a molecular mechanism of protection against alcoholic liver disease","volume":"14","author":"Hao","year":"2018","journal-title":"Redox Biol"},{"key":"2025081719112701000_1.2.e100020.23","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201707443","article-title":"A hepatocyte-mimicking antidote for alcohol intoxication","volume":"30","author":"Xu","year":"2018","journal-title":"Adv Mater"},{"key":"2025081719112701000_1.2.e100020.24","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100560","article-title":"Linking dysregulated AMPK signaling and ER stress in ethanol-induced liver injury in hepatic alcohol dehydrogenase deficient deer mice","volume":"9","author":"Srinivasan","year":"2019","journal-title":"Biomolecules"},{"key":"2025081719112701000_1.2.e100020.25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/alcalc\/agz091","article-title":"Roles of two major alcohol dehydrogenases, ADH1 (class I) and ADH3 (class III), in the adaptive enhancement of alcohol metabolism induced by chronic alcohol consumption in mice","volume":"55","author":"Haseba","year":"2020","journal-title":"Alcohol Alcohol"},{"key":"2025081719112701000_1.2.e100020.26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.041"},{"key":"2025081719112701000_1.2.e100020.27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.livres.2018.09.004","article-title":"Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease","volume":"2","author":"Khambu","year":"2018","journal-title":"Liver Res"},{"key":"2025081719112701000_1.2.e100020.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.05.027"},{"key":"2025081719112701000_1.2.e100020.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.01.011"},{"key":"2025081719112701000_1.2.e100020.30","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12904"},{"key":"2025081719112701000_1.2.e100020.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.08.011"},{"key":"2025081719112701000_1.2.e100020.32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbrc.2011.11.097","article-title":"Proteasome activity and autophagosome content in liver are reciprocally regulated by ethanol treatment","volume":"417","author":"Thomes","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"2025081719112701000_1.2.e100020.33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep4.1063","article-title":"Ethanol-induced steatosis involves impairment of lipophagy, associated with reduced dynamin2 activity","volume":"1","author":"Rasineni","year":"2017","journal-title":"Hepatol Commun"},{"key":"2025081719112701000_1.2.e100020.34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep4.1021","article-title":"Ethanol exposure inhibits hepatocyte lipophagy by inactivating the small guanosine triphosphatase Rab7","volume":"1","author":"Schulze","year":"2017","journal-title":"Hepatol Commun"},{"key":"2025081719112701000_1.2.e100020.35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jcmgh.2023.01.016","article-title":"Loss of SQSTM1\/P62 induces obesity and exacerbates alcohol-induced liver injury in aged mice","volume":"15","author":"Qian","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025081719112701000_1.2.e100020.36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32604"},{"key":"2025081719112701000_1.2.e100020.37","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102730","article-title":"Activation of mTORC1 by free fatty acids suppresses LAMP2 and autophagy function via ER stress in alcohol-related liver disease","volume":"10","author":"Guo","year":"2021","journal-title":"Cells"},{"key":"2025081719112701000_1.2.e100020.38","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jcmgh.2021.07.002","article-title":"Fatty acids inhibit LAMP2-mediated Autophagy flux via activating ER stress pathway in alcohol-related liver disease","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025081719112701000_1.2.e100020.39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/HEP.0000000000000373","article-title":"Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis","volume":"78","author":"Chao","year":"2023","journal-title":"Hepatology"},{"key":"2025081719112701000_1.2.e100020.40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24423"},{"key":"2025081719112701000_1.2.e100020.41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24018"},{"key":"2025081719112701000_1.2.e100020.42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00380.2011"},{"key":"2025081719112701000_1.2.e100020.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.11.008"},{"key":"2025081719112701000_1.2.e100020.44","doi-asserted-by":"publisher","DOI":"10.1002\/HEP.31496"},{"key":"2025081719112701000_1.2.e100020.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003"},{"key":"2025081719112701000_1.2.e100020.46","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/Farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"key":"2025081719112701000_1.2.e100020.47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.375907"},{"key":"2025081719112701000_1.2.e100020.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0386-0"},{"key":"2025081719112701000_1.2.e100020.49","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M058610"},{"key":"2025081719112701000_1.2.e100020.50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157898","article-title":"Fibroblast growth factor 21 response in a preclinical alcohol model of acute-on-chronic liver injury","volume":"22","author":"Christidis","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025081719112701000_1.2.e100020.51","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.molmet.2017.08.004","article-title":"Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury","volume":"6","author":"Desai","year":"2017","journal-title":"Molecular Metabolism"},{"key":"2025081719112701000_1.2.e100020.52","doi-asserted-by":"crossref","first-page":"31026","DOI":"10.1038\/srep31026","article-title":"Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"2025081719112701000_1.2.e100020.53","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/abbs\/gmu097","article-title":"FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway","volume":"46","author":"Zhu","year":"2014","journal-title":"ABBS"},{"key":"2025081719112701000_1.2.e100020.54","doi-asserted-by":"publisher","DOI":"10.1016\/J.CMET.2021.12.024"},{"key":"2025081719112701000_1.2.e100020.55","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.3390\/cells10123333","article-title":"Deficiency of cathelicidin attenuates high-fat diet plus alcohol-induced liver injury through FGF21\/adiponectin regulation","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"key":"2025081719112701000_1.2.e100020.56","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025081719112701000_1.2.e100020.57","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365"},{"key":"2025081719112701000_1.2.e100020.58","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32774"},{"key":"2025081719112701000_1.2.e100020.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.036"},{"key":"2025081719112701000_1.2.e100020.60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: the growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"key":"2025081719112701000_1.2.e100020.61","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00381-6"},{"key":"2025081719112701000_1.2.e100020.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00639-3"},{"key":"2025081719112701000_1.2.e100020.63","doi-asserted-by":"crossref","first-page":"155264","DOI":"10.1016\/j.metabol.2022.155264","article-title":"Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: an overview and current perspectives","volume":"134","author":"Yan","year":"2022","journal-title":"Metabolism"},{"key":"2025081719112701000_1.2.e100020.64","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0194","article-title":"Treating inflammation to combat non-alcoholic fatty liver disease","volume":"256","author":"Wiering","year":"2023","journal-title":"J Endocrinol"},{"key":"2025081719112701000_1.2.e100020.65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147841","article-title":"Pathogenesis and therapeutic strategies related to non-alcoholic fatty liver disease","volume":"23","author":"Teng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025081719112701000_1.2.e100020.66","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025081719112701000_1.2.e100020.67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954869","article-title":"The immune response as a therapeutic target in non-alcoholic fatty liver disease","volume":"13","author":"Ortiz-L\u00f3pez","year":"2022","journal-title":"Front Immunol"},{"key":"2025081719112701000_1.2.e100020.68","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1093\/hmg\/ddac088","article-title":"Role of non-coding RNAs on liver metabolism and NAFLD pathogenesis","volume":"31","author":"Qian","year":"2022","journal-title":"Hum Mol Genet"},{"key":"2025081719112701000_1.2.e100020.69","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.3748\/wjg.v28.i35.5111","article-title":"Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease","volume":"28","author":"Zaiou","year":"2022","journal-title":"World J Gastroenterol"},{"key":"2025081719112701000_1.2.e100020.70","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101581","article-title":"Micrornas in non-alcoholic fatty liver disease: progress and perspectives","volume":"65","author":"Hochreuter","year":"2022","journal-title":"Mol Metab"},{"key":"2025081719112701000_1.2.e100020.71","doi-asserted-by":"crossref","first-page":"C588","DOI":"10.1152\/ajpcell.00253.2022","article-title":"Circulating microRNAs associated with non-alcoholic fatty liver disease","volume":"324","author":"Atic","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"2025081719112701000_1.2.e100020.72","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","article-title":"miRNAs in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"69","author":"Liu","year":"2018","journal-title":"J Hepatol"},{"key":"2025081719112701000_1.2.e100020.73","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101244","article-title":"Hepatocyte miR-34A is a key regulator in the development and progression of non-alcoholic fatty liver disease","volume":"51","author":"Xu","year":"2021","journal-title":"Mol Metab"},{"key":"2025081719112701000_1.2.e100020.74","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/hep.31423","article-title":"Liver X receptor alpha activation inhibits autophagy and lipophagy in hepatocytes by dysregulating autophagy-related 4B cysteine peptidase and Rab-8B","volume":"73","author":"Kim","year":"2021","journal-title":"Hepatology"},{"key":"2025081719112701000_1.2.e100020.75","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34A-HNF4Alpha pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat Commun"},{"key":"2025081719112701000_1.2.e100020.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.04.004"},{"key":"2025081719112701000_1.2.e100020.77","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12135"},{"key":"2025081719112701000_1.2.e100020.78","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.094524"},{"key":"2025081719112701000_1.2.e100020.79","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R116.760884"},{"key":"2025081719112701000_1.2.e100020.80","doi-asserted-by":"crossref","first-page":"16054","DOI":"10.3390\/ijms232416054","article-title":"Long noncoding RNAs in the pathogenesis of insulin resistance","volume":"23","author":"Yang","year":"2022","journal-title":"IJMS"},{"key":"2025081719112701000_1.2.e100020.81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2022.06.001","article-title":"Long non-coding RNA in non-alcoholic fatty liver disease","volume":"110","author":"Rohilla","year":"2022","journal-title":"Adv Clin Chem"},{"key":"2025081719112701000_1.2.e100020.82","doi-asserted-by":"publisher","DOI":"10.1038\/srep20559"},{"key":"2025081719112701000_1.2.e100020.83","doi-asserted-by":"crossref","unstructured":"Liu J , Tang T , Wang G-D , et al . LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130A\/PPAR\u03b3 axis in non-alcoholic fatty liver disease. Bioscience Reports 2019;39. doi:10.1042\/BSR20181722","DOI":"10.1042\/BSR20181722"},{"key":"2025081719112701000_1.2.e100020.84","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/jcmm.14818","article-title":"Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2025081719112701000_1.2.e100020.85","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29654"},{"key":"2025081719112701000_1.2.e100020.86","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-04483-0","article-title":"Downregulation of hepatic lncRNA Gm19619 improves gluconeogenesis and lipogenesis following vertical sleeve gastrectomy in mice","volume":"6","author":"Fang","year":"2023","journal-title":"Commun Biol"},{"key":"2025081719112701000_1.2.e100020.87","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1089359","article-title":"The role of bile acid metabolism in the occurrence and development of NAFLD","volume":"9","author":"Bing","year":"2022","journal-title":"Front Mol Biosci"},{"key":"2025081719112701000_1.2.e100020.88","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41401-022-00880-z","article-title":"Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease","volume":"43","author":"Jiao","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"2025081719112701000_1.2.e100020.89","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.34.1885"},{"key":"2025081719112701000_1.2.e100020.90","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33041-7"},{"key":"2025081719112701000_1.2.e100020.91","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metabolism"},{"key":"2025081719112701000_1.2.e100020.92","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76738"},{"key":"2025081719112701000_1.2.e100020.93","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26937"},{"key":"2025081719112701000_1.2.e100020.94","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29544"},{"key":"2025081719112701000_1.2.e100020.95","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.417014"},{"key":"2025081719112701000_1.2.e100020.96","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300304"},{"key":"2025081719112701000_1.2.e100020.97","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0016"},{"key":"2025081719112701000_1.2.e100020.98","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00558-8"},{"key":"2025081719112701000_1.2.e100020.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.012"},{"key":"2025081719112701000_1.2.e100020.100","doi-asserted-by":"publisher","DOI":"10.1159\/000518407"},{"key":"2025081719112701000_1.2.e100020.101","doi-asserted-by":"crossref","first-page":"166480","DOI":"10.1016\/j.bbadis.2022.166480","article-title":"Macrophage-specific Myd88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response","volume":"1868","author":"Yang","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2025081719112701000_1.2.e100020.102","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105802","article-title":"Mapping transcriptional heterogeneity and metabolic networks in fatty livers at single-cell resolution","volume":"26","author":"Coassolo","year":"2023","journal-title":"iScience"},{"key":"2025081719112701000_1.2.e100020.103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add3949","article-title":"An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis","volume":"15","author":"Wang","year":"2023","journal-title":"Sci Transl Med"},{"key":"2025081719112701000_1.2.e100020.104","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s40618-022-01773-y","article-title":"Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)","volume":"45","author":"Wang","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"2025081719112701000_1.2.e100020.105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16754-7","article-title":"Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis","volume":"12","author":"Fred","year":"2022","journal-title":"Sci Rep"},{"key":"2025081719112701000_1.2.e100020.106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038401","article-title":"Single-cell RNA sequencing reveals a novel inhibitory effect of ApoA4 on NAFL mediated by liver-specific subsets of myeloid cells","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"2025081719112701000_1.2.e100020.107","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cmet.2022.07.010","article-title":"Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment","volume":"34","author":"Zhang","year":"2022","journal-title":"Cell Metab"},{"key":"2025081719112701000_1.2.e100020.108","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"2025081719112701000_1.2.e100020.109","doi-asserted-by":"crossref","first-page":"103233","DOI":"10.1016\/j.isci.2021.103233","article-title":"Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver","volume":"24","author":"Su","year":"2021","journal-title":"iScience"},{"key":"2025081719112701000_1.2.e100020.110","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31743"},{"key":"2025081719112701000_1.2.e100020.111","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025081719112701000_1.2.e100020.112","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.07.028"},{"key":"2025081719112701000_1.2.e100020.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.001"},{"key":"2025081719112701000_1.2.e100020.114","doi-asserted-by":"crossref","unstructured":"Hou J , Zhang J , Cui P , et al . TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis. J Clin Invest 2021;131. doi:10.1172\/JCI135197","DOI":"10.1172\/JCI135197"},{"key":"2025081719112701000_1.2.e100020.115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.004"},{"key":"2025081719112701000_1.2.e100020.116","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263"},{"key":"2025081719112701000_1.2.e100020.117","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.046"},{"key":"2025081719112701000_1.2.e100020.118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.05.009"},{"key":"2025081719112701000_1.2.e100020.119","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"2025081719112701000_1.2.e100020.120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"2025081719112701000_1.2.e100020.121","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03362-0"},{"key":"2025081719112701000_1.2.e100020.122","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJMcibr2106594","article-title":"Hepatocellular carcinoma - origins and outcomes","volume":"385","author":"Phimister","year":"2021","journal-title":"N Engl J Med"},{"key":"2025081719112701000_1.2.e100020.123","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/med.21727","article-title":"Reinvigorating exhausted CD8(+) cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy","volume":"41","author":"Hossain","year":"2021","journal-title":"Med Res Rev"},{"key":"2025081719112701000_1.2.e100020.124","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.69"},{"key":"2025081719112701000_1.2.e100020.125","first-page":"S168","article-title":"Mitochondrial dynamics and stasis are critical for hepatocyte function and liver tumorigenesis","volume":"76","author":"Ma","year":"2022","journal-title":"Hepatology"},{"key":"2025081719112701000_1.2.e100020.126","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.158","article-title":"Loss of pten synergizes with C-met to promote hepatocellular carcinoma development via mTORC2 pathway","volume":"50","author":"Xu","year":"2018","journal-title":"Exp Mol Med"},{"key":"2025081719112701000_1.2.e100020.127","doi-asserted-by":"crossref","unstructured":"Fu Y , Mackowiak B , Feng D , et al . Microrna-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression. Gut 2023:gutjnl-2022-327924. doi:10.1136\/gutjnl-2022-327924","DOI":"10.1136\/gutjnl-2022-327924"},{"key":"2025081719112701000_1.2.e100020.128","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.32412","article-title":"A developmentally prometastatic niche to hepatoblastoma in neonatal liver mediated by the Cxcl1\/Cxcr2 axis","volume":"76","author":"Fan","year":"2022","journal-title":"Hepatology"},{"key":"2025081719112701000_1.2.e100020.129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-0041-1729970","article-title":"Toward a liver cell atlas: understanding liver biology in health and disease at single-cell resolution","volume":"41","author":"Ma","year":"2021","journal-title":"Semin Liver Dis"},{"key":"2025081719112701000_1.2.e100020.130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.trecan.2021.12.001","article-title":"Dissecting liver tumor heterogeneity to improve health equity","volume":"8","author":"Ma","year":"2022","journal-title":"Trends Cancer"},{"key":"2025081719112701000_1.2.e100020.131","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.32345","article-title":"Single-cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC","volume":"76","author":"Khatib","year":"2022","journal-title":"Hepatology"},{"key":"2025081719112701000_1.2.e100020.132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.08.007"},{"key":"2025081719112701000_1.2.e100020.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.028"},{"key":"2025081719112701000_1.2.e100020.134","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.003"},{"key":"2025081719112701000_1.2.e100020.135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune Microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"2025081719112701000_1.2.e100020.136","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-35291-5","article-title":"Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer","volume":"13","author":"Ma","year":"2022","journal-title":"Nat Commun"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2023-100020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T02:15:56Z","timestamp":1755483356000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2023-100020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":136,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,19]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/egastro-2023-100020"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2023-100020","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}